Medinice S.A (ICE) - Total Liabilities
Based on the latest financial reports, Medinice S.A (ICE) has total liabilities worth zł4.62 Million PLN (≈ $1.27 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Medinice S.A liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Medinice S.A - Total Liabilities Trend (2016–2025)
This chart illustrates how Medinice S.A's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Medinice S.A asset portfolio.
Medinice S.A Competitors by Total Liabilities
The table below lists competitors of Medinice S.A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
msg life ag
HM:MSGL
|
Germany | €36.56 Million |
|
Bhartiya International Limited
NSE:BIL
|
India | Rs8.45 Billion |
|
Rav Bariach 08 Industries Ltd
TA:BRIH
|
Israel | ILA955.82 Million |
|
Private Equity Holding AG
SW:PEHN
|
Switzerland | CHF28.24 Million |
|
Corbus Pharmaceuticals Holding
NASDAQ:CRBP
|
USA | $24.75 Million |
|
Plenitude Bhd
KLSE:5075
|
Malaysia | RM771.64 Million |
|
Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP
|
USA | $32.02 Million |
|
Admicom Oyj
HE:ADMCM
|
Finland | €5.98 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down Medinice S.A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See ICE net asset quality score to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.87 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.05 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.05 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Medinice S.A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Medinice S.A (2016–2025)
The table below shows the annual total liabilities of Medinice S.A from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | zł4.62 Million ≈ $1.27 Million |
-17.50% |
| 2024-12-31 | zł5.59 Million ≈ $1.54 Million |
+29.28% |
| 2023-12-31 | zł4.33 Million ≈ $1.19 Million |
-9.31% |
| 2022-12-31 | zł4.77 Million ≈ $1.31 Million |
-44.50% |
| 2021-12-31 | zł8.60 Million ≈ $2.37 Million |
+118.03% |
| 2020-12-31 | zł3.94 Million ≈ $1.09 Million |
+14.06% |
| 2019-12-31 | zł3.46 Million ≈ $951.41K |
-25.43% |
| 2018-12-31 | zł4.64 Million ≈ $1.28 Million |
+183.09% |
| 2017-12-31 | zł1.64 Million ≈ $450.70K |
+25.54% |
| 2016-12-31 | zł1.30 Million ≈ $359.00K |
-- |
About Medinice S.A
Medinice S.A., a medical technology company, creates, develops, and commercializes minimally invasive solutions in cardiology and cardiac surgery. The company offers PacePress, a medical device to reduce the risk of complications following the implantation of cardiac electrotherapeutic devices, such as pacemakers or implantable cardioverter-defibrillators; CoolCryo, a cardiac cryoablation technol… Read more